Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression

Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder caused by monoallelic mutation or deletion in the ( ) gene. Individuals with PTHS typically present in the first year of life with developmental delay and exhibit intellectual disability, lack of speech, and motor incoordination. There ar...

Full description

Saved in:
Bibliographic Details
Published in:eLife Vol. 11
Main Authors: Kim, Hyojin, Gao, Eric B, Draper, Adam, Berens, Noah C, Vihma, Hanna, Zhang, Xinyuan, Higashi-Howard, Alexandra, Ritola, Kimberly D, Simon, Jeremy M, Kennedy, Andrew J, Philpot, Benjamin D
Format: Journal Article
Language:English
Published: England eLife Science Publications, Ltd 10-05-2022
eLife Sciences Publications Ltd
eLife Sciences Publications, Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder caused by monoallelic mutation or deletion in the ( ) gene. Individuals with PTHS typically present in the first year of life with developmental delay and exhibit intellectual disability, lack of speech, and motor incoordination. There are no effective treatments available for PTHS, but the root cause of the disorder, haploinsufficiency, suggests that it could be treated by normalizing gene expression. Here, we performed proof-of-concept viral gene therapy experiments using a conditional mouse model of PTHS and found that postnatally reinstating expression in neurons improved anxiety-like behavior, activity levels, innate behaviors, and memory. Postnatal reinstatement also partially corrected EEG abnormalities, which we characterized here for the first time, and the expression of key TCF4-regulated genes. Our results support a genetic normalization approach as a treatment strategy for PTHS, and possibly other TCF4-linked disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Life Edit Therapeutics, Morrisville, United States.
Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.
ISSN:2050-084X
2050-084X
DOI:10.7554/eLife.72290